Impact of GERD on daily life (NIS) - Alegria

Study identifier:NIS-GBE-NEX-2006/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An epidemiological, observational study to describe symptom control and impact on daily life of GERD in patients with erosive gastroesophageal reflux disease.

Medical condition

GERD

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

2001

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Jun 2006
Primary Completion Date: -
Study Completion Date: 01 Mar 2008

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2012 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria